Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyacrylamide hydrogel is a synthetic, three-dimensional, cross-linked polymer network made from polyacrylamide and water, typically consisting of about 2.5% cross-linked polyacrylamide and 97.5% nonpyrogenic water[2]. It is known for its high water absorption capacity, biocompatibility, and mechanical adaptability, mimicking the properties of natural living tissues[1]. This hydrogel is widely utilized as a biomaterial in medical devices, wound dressings, controlled drug delivery systems, and implants[1][2][3]. Its mechanism of action centers on absorbing water by forming hydrogen bonds (osmosis), maintaining a moist environment for wound healing, and serving as a tunable matrix for controlled release of incorporated therapeutics[1][2]. Polyacrylamide-based hydrogels also act as anti-fouling coatings for implants, reducing foreign body response and local inflammation[3]. The hydrogel can be further tailored in composition and physical structure to optimize porosity, mechanical strength, and biocompatibility for specific biomedical uses[3]. It is nonresorbable, stable, and exhibits low toxicity[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyacrylamide hydrogel.